Swiss National Bank
CINC

Swiss National Bank’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Swiss National Bank’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40,200
Closed -$494K – 2698
2022
Q4 		$494K Hold
40,200
– – ﹤0.01% 2575
2022
Q3 		$1.32M Buy
40,200
+9,100
+29% +$257K ﹤0.01% 2163
2022
Q2 		$586K Buy
+31,100
New +$595K ﹤0.01% 2574

Swiss National Bank's CINC Position: Q1 2023 in Review

Swiss National Bank sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 40,200 shares — an estimated $494K sold.

Swiss National Bank first reported a position in CINC in Q2 2022 and held it in 3 quarters. The position peaked at $1.32M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Swiss National Bank reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Swiss National Bank sold 40,200 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $494K.
  • Swiss National Bank first reported a position in CinCor Pharma, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Swiss National Bank's CinCor Pharma, Inc. Common Stock position peaked at $1.32M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.